Prosecution Insights
Last updated: October 04, 2026

Refeyn Ltd.

Technology area: Semiconductors, Circuits & Optics

2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Refeyn Ltd. maintains a patent portfolio focused on the Semiconductors, Circuits & Optics technology area. The company currently manages 2 pending office actions. These actions are distributed across 2 distinct examiners, though they remain centralized within 1 distinct art unit. This structure suggests that while the technical subject matter is consistent enough to stay within a single art unit, the prosecution is being handled by multiple individuals at the patent office. This can lead to differing examiner perspectives on similar technical disclosures.

RUFUS L PHILLIPS is the busiest examiner associated with the portfolio. This examiner is currently handling 1 busiest examiner pending office action. Because there are 2 pending office actions in total across 2 distinct examiners, the workload is split, with each examiner managing an action. For practitioners, this means engagement is required with multiple examiners despite the singular art unit classification. Navigating this environment involves addressing the specific requirements of each examiner while maintaining a cohesive strategy for the Semiconductors, Circuits & Optics technology.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (50%)
1
Medium (50%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (50%)
§103 only1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
2
Semiconductors
100% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PHILLIPS, RUFUS L 1 62.6% +32.1%
RAHMAN, MD M 1 92.3% +12.1%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18579572 METHOD OF DETERMINING THE IDENTITY OF A BIOMOLECULE RAHMAN, MD M —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18294701 INTERFEROMETRIC SCATTERING MICROSCOPY PHILLIPS, RUFUS L 43d overdue
18579572 METHOD OF DETERMINING THE IDENTITY OF A BIOMOLECULE RAHMAN, MD M —

Top Art Units

Art UnitApps
2877 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18294701 INTERFEROMETRIC SCATTERING MICROSCOPY PHILLIPS, RUFUS L 2877 §103 Final Rejection 43d overdue Pending Feb 02, 2024
18579572 METHOD OF DETERMINING THE IDENTITY OF A BIOMOLECULE RAHMAN, MD M 2877 §101 Non-Final OA — Pending Jan 16, 2024

Managing Refeyn Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month